Brief: Insilico Medicine Cayman Topco Receives NMPA IND Approval For ISM8969/HT-001
03/08/2026 02:41
BRIEF-Insilico Medicine Cayman Topco Receives NMPA IND Approval For ISM8969/HT-001 Aug 3 (Reuters) - Insilico Medicine Cayman TopCo 3696.HK:
RECEIVES NMPA IND APPROVAL FOR ISM8969/HT-001
Further company coverage: 3696.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insilico Medicine Cayman TopCo
See all newsInSilico Medicine jumps on progress in testing of new weight-loss drug
Development Collaboration
InSilico jumps on collaboration to develop biological frontier foundation models
HK-listed InSilico Medicine climbs as chairman buys shares
Brief: Insilico Medicine Cayman Topco's Chair Purchases Aggregate 113,500 Shares In Sept 4-7